Choose a language and wait for the translated text.
In an intimation to the stock exchange, the company said its Bachupally, Hyderabad-based formulations manufacturing facility (FTO-3) underwent an inspection from August 6 to 14 and have been issued a Form 483 with four observations.
Dr Reddy’s formulations facility gets 4 observations from FDA | PharmaVoice
